Difference between revisions of "How I Treat"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 43: Line 43:
 
*'''2018:''' Brown JR. How I treat CLL patients with ibrutinib. Blood. 2018 Jan 25;131(4):379-386. [https://doi.org/10.1182/blood-2017-08-764712 link to original article] [https://pubmed.ncbi.nlm.nih.gov/29255067/ PubMed]
 
*'''2018:''' Brown JR. How I treat CLL patients with ibrutinib. Blood. 2018 Jan 25;131(4):379-386. [https://doi.org/10.1182/blood-2017-08-764712 link to original article] [https://pubmed.ncbi.nlm.nih.gov/29255067/ PubMed]
  
===[[Classical Hodgkin lymphoma|Classical Hodgkin lymphoma (cHL)]]===
+
===Hodgkin lymphoma===
 
*'''2021:''' Epperla & Herrera [https://doi.org/10.1182/blood.2020007900 How I incorporate novel agents into the treatment of classical Hodgkin lymphoma]
 
*'''2021:''' Epperla & Herrera [https://doi.org/10.1182/blood.2020007900 How I incorporate novel agents into the treatment of classical Hodgkin lymphoma]
 +
*'''2020:''' Eichenauer & Engert [https://doi.org/10.1182/blood.2019004044 How I treat nodular lymphocyte-predominant Hodgkin Lymphoma]
  
 
===[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]]===
 
===[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]]===
 
*'''2023:''' Lugtenburg & Mutsaers [https://doi.org/10.1182/blood.2020008239 How I treat older patients with DLBCL in the frontline setting] [https://pubmed.ncbi.nlm.nih.gov/36413153/ PubMed]
 
*'''2023:''' Lugtenburg & Mutsaers [https://doi.org/10.1182/blood.2020008239 How I treat older patients with DLBCL in the frontline setting] [https://pubmed.ncbi.nlm.nih.gov/36413153/ PubMed]
 +
 +
===[[Follicular lymphoma|Follicular lymphoma (FL)]]===
 +
*'''2019:''' Casulo & Barr [https://doi.org/10.1182/blood-2018-08-822148 How I treat early-relapsing follicular lymphoma] [https://pubmed.ncbi.nlm.nih.gov/30700421/ PubMed]
 +
 +
===[[Waldenström macroglobulinemia|Waldenström macroglobulinemia (WM)]]===
 +
*'''2019:''' Dimopoulos & Kastritis. [https://doi.org/10.1182/blood.2019000725 How I treat Waldenström macroglobulinemia] [https://pubmed.ncbi.nlm.nih.gov/31527073/ PubMed]
  
 
==Plasma cell dyscrasias==
 
==Plasma cell dyscrasias==

Revision as of 01:49, 7 September 2023

The "How I Treat" series has been published by Blood for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles are not considered to be formal guidelines, they are considered high-level expert opinion. They cover topics ranging from commonly encountered hematologic conditions with a large evidence base, to very rare conditions with only case reports to guide treatment. The purpose of this page is to consolidate the links to all known published How I Treat articles.

Articles are presented by condition, in reverse chronological order. Given the rapid change in evidence in many areas of hematology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Note: this page is currently under construction.

Malignant hematology

Myeloid neoplasms

Acute lymphoblastic leukemia (ALL)

Acute myeloid leukemia (AML)

Chronic myeloid leukemia (CML)

Myelodysplastic syndrome (MDS)

Polycythemia vera (PV)

Lymphoid neoplasms

Chronic lymphocytic leukemia (CLL/SLL)

Hodgkin lymphoma

Diffuse large B-cell lymphoma (DLBCL)

Follicular lymphoma (FL)

Waldenström macroglobulinemia (WM)

Plasma cell dyscrasias

Histiocytic disorders

Classical hematology

Complications of treatment